SOMERSET, N.J., May 13, 2010 (GLOBE NEWSWIRE) -- Bob Chandler, principal and co-founder of the Chandler Chicco Companies, part of inVentiv Health (Nasdaq:VTIV), received a SABRE Award for Individual Achievement at Tuesday evening's 2010 U.S. SABRE Awards ceremony, hosted by The Holmes Group.
Chandler received the award, which honors the exceptional work of public relations professionals, in recognition of his "bold vision [for a firm] built on strong values and a people-first approach," and his leadership of "some of the most significant healthcare communications campaigns of recent years." Chandler is one of three award recipients this year, who also include Jon Iwata, IBM's Senior Vice President, Marketing and Communications, and Carol Cone, founder of Cone LLC, one of the top corporate responsibility communication agencies in the country.
"It is truly an honor to be the recipient of this award, especially as Chandler Chicco celebrates our 15th anniversary this year," said Chandler. "I want to share this award with the incredibly talented and dedicated people I've been proud to call colleagues, clients and friends along this journey, and who continue to inspire me every day."
Chandler and his long-time business partner Gianfranco Chicco founded the Chandler Chicco Agency in 1995, and today it is the world's leading healthcare public relations firm, employing more than 300 people across offices in New York, London, Los Angeles, Washington and Paris. Chandler Chicco was named "Healthcare Agency of the Decade" by The Holmes Report in January 2010 – a decade in which Chandler Chicco quadrupled in size, expanded into European markets, developed design, research and advertising capability, and became part of healthcare services company inVentiv Health in 2007. The agency currently offers public relations and communications counsel to a list of over 40 clients, including hospitals, NGOs, healthcare associations, coalitions, and many of the world's largest pharmaceutical companies.
About Chandler Chicco Companies
Chandler Chicco Companies (CCC) is a network of global companies representing best-in-class capabilities in healthcare communications across public relations, marketing and branding, digital and social media, graphic design, media and production, and research and measurement. Current CCC companies include: Chandler Chicco Agency, Biosector 2, Litmus, Determinus, 'nition, Allidura Consumer, Brandtectonics, VerStone Digital and Chandler Chicco Productions.
CCC has wholly-owned offices in London, Los Angeles, Paris, New York and Washington, DC and also has a global affiliate healthcare network of 22 national companies operating across 37 markets. For more information, visit www.chandlerchiccocompanies.com
About inVentiv Health
inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com/">www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.